Published in Vaccine Weekly, September 25th, 1995
Previous vaccines required part of the patient's own tumor. A vaccine made from a generalized tumor would be easier and less expensive to produce, said Dr. Ronald Hornung, an author of the study published in the Journal of the National Cancer Institute.
Studies show such vaccines help fight slow-growing cancers resistant to chemotherapy or other treatments.
In this study, mice with cancerous tumors received bone-marrow transplants...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly